INHALED TRIPLE THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: TRIBUTE CLINICAL STUDY DATA
Journal Title: Pulmonologija ir alergologija - Year 2018, Vol 2, Issue 1
Abstract
Chronic obstructive pulmonary disease (COPD) is characterised by persistent respiratory symptoms and airflow limitation. Due to disease severity, exacerbations, exacerbations, affecting the quality of life, become more frequent, accelerate the progression of the disease. Dual therapy is often insufficient to reduce frequency of COPD exacerbation. Treatment with three different pharmacotherapeutic groups of inhaled medications is superior to dual bronchodilator therapy (TRIBUTE clinical study data): a significant reduction in the moderate-to-severe COPD exacerbations. It was observed improvement of health-related quality of life, lung function, without differences in safety profile. Also, in the analysis of the results, it was observed that BDP / FF / G treatment was particularly effective in the presence of chronic bronchitis COPD phenotype with elevated peripheral blood eosinophil (>2%). Such treatment is promising for long-term treatment of COPD in carefully selected patients.
Authors and Affiliations
Virginija Kalinauskaitė-Žukauskė
HIGHLIGHTS FOR INSOMNIA DIAGNOSTICS AND TREATMENT
Insomnia is one of the most common sleep disorders, characterised by repeated disability to fall asleep or continue to sleep, and worsened sleep quality, that affects daytime functioning and does not reveal in spite of a...
EFFICACY OF OMALIZUMAB TREATMENT FOR PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA
Background. Chronic spontaneous urticaria is defined as itchy hives, lasting for 6 and more weeks, with or without angioedema. Part of the patients do not have a response to a standard therapy with H1 antihistamines even...
LITHUANIAN RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF OBSTRUCTIVE SLEEP APNEA
These recommendations establish clinical practice guidelines for the diagnosis and treatment of adult and children obstructive sleep apnea.
LABORATORY DIAGNOSTICS FOR SYSTEMIC AUTOIMMUNE DISEASES WITH PULMONARY INVOLVEMENT
Most of the systemic autoimmune diseases are related to multiorgan involvement. As expected in such a disease, the entire pulmonary system is vulnerable to injury. In this article, we present systemic autoimmune diseases...
DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
Chronic thromboembolic pulmonary hypertension (CTEPH) is a distinct form of pulmonary hypertension due to chronic obstruction of the pulmonary artery tree. If left untreated, the prognosis is poor. Pulmonary endarterect...